[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Piriformis Syndrome Market Growth (Status and Outlook) 2024-2030

May 2024 | 109 pages | ID: G1CA02C9767CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Piriformis syndrome is a rare neuromuscular condition that is caused when the piriformis muscle compresses the sciatic nerve. The piriformis muscle is a flat, band-like muscle located in the buttock near the upper region of the hip joint. Piriformis syndrome mostly occurs in adults and can affect individuals from any field and activity levels. The common causes of piriformis syndrome are considered to be trauma, spasms, and overuse injury. Additionally, according to the National Center for Biotechnology Information (NCBI), the piriformis syndrome is more prevalent in patients with pain in the lower back.

The global Piriformis Syndrome market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Piriformis Syndrome Industry Forecast” looks at past sales and reviews total world Piriformis Syndrome sales in 2023, providing a comprehensive analysis by region and market sector of projected Piriformis Syndrome sales for 2024 through 2030. With Piriformis Syndrome sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piriformis Syndrome industry.

This Insight Report provides a comprehensive analysis of the global Piriformis Syndrome landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Piriformis Syndrome portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Piriformis Syndrome market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piriformis Syndrome and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piriformis Syndrome.

The North American region is anticipated to dominate the market due to the existing well-established healthcare system, increasing healthcare expenditure, growing awareness about the syndrome, and rising geriatric population.

This report presents a comprehensive overview, market shares, and growth opportunities of Piriformis Syndrome market by product type, application, key players and key regions and countries.

Segmentation by type
  • Medication
  • Physical Therapy
  • Others
Segmentation by application
  • Hospitals
  • Clinics
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Novartis
  • Sanofi
  • Bayer
  • AstraZeneca
  • Teva Pharmaceuticals
  • Endo Pharmaceuticals
  • Omron Healthcare
  • DePuy Synthes
  • Miracle Stretch
  • Seirin Corporation
  • Nidd Valley Medical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Piriformis Syndrome Market Size 2019-2030
  2.1.2 Piriformis Syndrome Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Piriformis Syndrome Segment by Type
  2.2.1 Medication
  2.2.2 Physical Therapy
  2.2.3 Others
2.3 Piriformis Syndrome Market Size by Type
  2.3.1 Piriformis Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Piriformis Syndrome Market Size Market Share by Type (2019-2024)
2.4 Piriformis Syndrome Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Piriformis Syndrome Market Size by Application
  2.5.1 Piriformis Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Piriformis Syndrome Market Size Market Share by Application (2019-2024)

3 PIRIFORMIS SYNDROME MARKET SIZE BY PLAYER

3.1 Piriformis Syndrome Market Size Market Share by Players
  3.1.1 Global Piriformis Syndrome Revenue by Players (2019-2024)
  3.1.2 Global Piriformis Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Piriformis Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PIRIFORMIS SYNDROME BY REGIONS

4.1 Piriformis Syndrome Market Size by Regions (2019-2024)
4.2 Americas Piriformis Syndrome Market Size Growth (2019-2024)
4.3 APAC Piriformis Syndrome Market Size Growth (2019-2024)
4.4 Europe Piriformis Syndrome Market Size Growth (2019-2024)
4.5 Middle East & Africa Piriformis Syndrome Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Piriformis Syndrome Market Size by Country (2019-2024)
5.2 Americas Piriformis Syndrome Market Size by Type (2019-2024)
5.3 Americas Piriformis Syndrome Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Piriformis Syndrome Market Size by Region (2019-2024)
6.2 APAC Piriformis Syndrome Market Size by Type (2019-2024)
6.3 APAC Piriformis Syndrome Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Piriformis Syndrome by Country (2019-2024)
7.2 Europe Piriformis Syndrome Market Size by Type (2019-2024)
7.3 Europe Piriformis Syndrome Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Piriformis Syndrome by Region (2019-2024)
8.2 Middle East & Africa Piriformis Syndrome Market Size by Type (2019-2024)
8.3 Middle East & Africa Piriformis Syndrome Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PIRIFORMIS SYNDROME MARKET FORECAST

10.1 Global Piriformis Syndrome Forecast by Regions (2025-2030)
  10.1.1 Global Piriformis Syndrome Forecast by Regions (2025-2030)
  10.1.2 Americas Piriformis Syndrome Forecast
  10.1.3 APAC Piriformis Syndrome Forecast
  10.1.4 Europe Piriformis Syndrome Forecast
  10.1.5 Middle East & Africa Piriformis Syndrome Forecast
10.2 Americas Piriformis Syndrome Forecast by Country (2025-2030)
  10.2.1 United States Piriformis Syndrome Market Forecast
  10.2.2 Canada Piriformis Syndrome Market Forecast
  10.2.3 Mexico Piriformis Syndrome Market Forecast
  10.2.4 Brazil Piriformis Syndrome Market Forecast
10.3 APAC Piriformis Syndrome Forecast by Region (2025-2030)
  10.3.1 China Piriformis Syndrome Market Forecast
  10.3.2 Japan Piriformis Syndrome Market Forecast
  10.3.3 Korea Piriformis Syndrome Market Forecast
  10.3.4 Southeast Asia Piriformis Syndrome Market Forecast
  10.3.5 India Piriformis Syndrome Market Forecast
  10.3.6 Australia Piriformis Syndrome Market Forecast
10.4 Europe Piriformis Syndrome Forecast by Country (2025-2030)
  10.4.1 Germany Piriformis Syndrome Market Forecast
  10.4.2 France Piriformis Syndrome Market Forecast
  10.4.3 UK Piriformis Syndrome Market Forecast
  10.4.4 Italy Piriformis Syndrome Market Forecast
  10.4.5 Russia Piriformis Syndrome Market Forecast
10.5 Middle East & Africa Piriformis Syndrome Forecast by Region (2025-2030)
  10.5.1 Egypt Piriformis Syndrome Market Forecast
  10.5.2 South Africa Piriformis Syndrome Market Forecast
  10.5.3 Israel Piriformis Syndrome Market Forecast
  10.5.4 Turkey Piriformis Syndrome Market Forecast
  10.5.5 GCC Countries Piriformis Syndrome Market Forecast
10.6 Global Piriformis Syndrome Forecast by Type (2025-2030)
10.7 Global Piriformis Syndrome Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Piriformis Syndrome Product Offered
  11.1.3 Novartis Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Piriformis Syndrome Product Offered
  11.2.3 Sanofi Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 Bayer
  11.3.1 Bayer Company Information
  11.3.2 Bayer Piriformis Syndrome Product Offered
  11.3.3 Bayer Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Bayer Main Business Overview
  11.3.5 Bayer Latest Developments
11.4 AstraZeneca
  11.4.1 AstraZeneca Company Information
  11.4.2 AstraZeneca Piriformis Syndrome Product Offered
  11.4.3 AstraZeneca Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 AstraZeneca Main Business Overview
  11.4.5 AstraZeneca Latest Developments
11.5 Teva Pharmaceuticals
  11.5.1 Teva Pharmaceuticals Company Information
  11.5.2 Teva Pharmaceuticals Piriformis Syndrome Product Offered
  11.5.3 Teva Pharmaceuticals Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Teva Pharmaceuticals Main Business Overview
  11.5.5 Teva Pharmaceuticals Latest Developments
11.6 Endo Pharmaceuticals
  11.6.1 Endo Pharmaceuticals Company Information
  11.6.2 Endo Pharmaceuticals Piriformis Syndrome Product Offered
  11.6.3 Endo Pharmaceuticals Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Endo Pharmaceuticals Main Business Overview
  11.6.5 Endo Pharmaceuticals Latest Developments
11.7 Omron Healthcare
  11.7.1 Omron Healthcare Company Information
  11.7.2 Omron Healthcare Piriformis Syndrome Product Offered
  11.7.3 Omron Healthcare Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Omron Healthcare Main Business Overview
  11.7.5 Omron Healthcare Latest Developments
11.8 DePuy Synthes
  11.8.1 DePuy Synthes Company Information
  11.8.2 DePuy Synthes Piriformis Syndrome Product Offered
  11.8.3 DePuy Synthes Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 DePuy Synthes Main Business Overview
  11.8.5 DePuy Synthes Latest Developments
11.9 Miracle Stretch
  11.9.1 Miracle Stretch Company Information
  11.9.2 Miracle Stretch Piriformis Syndrome Product Offered
  11.9.3 Miracle Stretch Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Miracle Stretch Main Business Overview
  11.9.5 Miracle Stretch Latest Developments
11.10 Seirin Corporation
  11.10.1 Seirin Corporation Company Information
  11.10.2 Seirin Corporation Piriformis Syndrome Product Offered
  11.10.3 Seirin Corporation Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Seirin Corporation Main Business Overview
  11.10.5 Seirin Corporation Latest Developments
11.11 Nidd Valley Medical
  11.11.1 Nidd Valley Medical Company Information
  11.11.2 Nidd Valley Medical Piriformis Syndrome Product Offered
  11.11.3 Nidd Valley Medical Piriformis Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Nidd Valley Medical Main Business Overview
  11.11.5 Nidd Valley Medical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Piriformis Syndrome Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Medication
Table 3. Major Players of Physical Therapy
Table 4. Major Players of Others
Table 5. Piriformis Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Piriformis Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Piriformis Syndrome Market Size Market Share by Type (2019-2024)
Table 8. Piriformis Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Piriformis Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Piriformis Syndrome Market Size Market Share by Application (2019-2024)
Table 11. Global Piriformis Syndrome Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Piriformis Syndrome Revenue Market Share by Player (2019-2024)
Table 13. Piriformis Syndrome Key Players Head office and Products Offered
Table 14. Piriformis Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Piriformis Syndrome Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Piriformis Syndrome Market Size Market Share by Regions (2019-2024)
Table 19. Global Piriformis Syndrome Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Piriformis Syndrome Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Piriformis Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Piriformis Syndrome Market Size Market Share by Country (2019-2024)
Table 23. Americas Piriformis Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Piriformis Syndrome Market Size Market Share by Type (2019-2024)
Table 25. Americas Piriformis Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Piriformis Syndrome Market Size Market Share by Application (2019-2024)
Table 27. APAC Piriformis Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Piriformis Syndrome Market Size Market Share by Region (2019-2024)
Table 29. APAC Piriformis Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Piriformis Syndrome Market Size Market Share by Type (2019-2024)
Table 31. APAC Piriformis Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Piriformis Syndrome Market Size Market Share by Application (2019-2024)
Table 33. Europe Piriformis Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Piriformis Syndrome Market Size Market Share by Country (2019-2024)
Table 35. Europe Piriformis Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Piriformis Syndrome Market Size Market Share by Type (2019-2024)
Table 37. Europe Piriformis Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Piriformis Syndrome Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Piriformis Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Piriformis Syndrome Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Piriformis Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Piriformis Syndrome Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Piriformis Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Piriformis Syndrome Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Piriformis Syndrome
Table 46. Key Market Challenges & Risks of Piriformis Syndrome
Table 47. Key Industry Trends of Piriformis Syndrome
Table 48. Global Piriformis Syndrome Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Piriformis Syndrome Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Piriformis Syndrome Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Piriformis Syndrome Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Novartis Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 53. Novartis Piriformis Syndrome Product Offered
Table 54. Novartis Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Sanofi Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 58. Sanofi Piriformis Syndrome Product Offered
Table 59. Sanofi Main Business
Table 60. Sanofi Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Sanofi Latest Developments
Table 62. Bayer Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 63. Bayer Piriformis Syndrome Product Offered
Table 64. Bayer Main Business
Table 65. Bayer Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bayer Latest Developments
Table 67. AstraZeneca Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 68. AstraZeneca Piriformis Syndrome Product Offered
Table 69. AstraZeneca Main Business
Table 70. AstraZeneca Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. AstraZeneca Latest Developments
Table 72. Teva Pharmaceuticals Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 73. Teva Pharmaceuticals Piriformis Syndrome Product Offered
Table 74. Teva Pharmaceuticals Main Business
Table 75. Teva Pharmaceuticals Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Teva Pharmaceuticals Latest Developments
Table 77. Endo Pharmaceuticals Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 78. Endo Pharmaceuticals Piriformis Syndrome Product Offered
Table 79. Endo Pharmaceuticals Main Business
Table 80. Endo Pharmaceuticals Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Endo Pharmaceuticals Latest Developments
Table 82. Omron Healthcare Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 83. Omron Healthcare Piriformis Syndrome Product Offered
Table 84. Omron Healthcare Main Business
Table 85. Omron Healthcare Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Omron Healthcare Latest Developments
Table 87. DePuy Synthes Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 88. DePuy Synthes Piriformis Syndrome Product Offered
Table 89. DePuy Synthes Main Business
Table 90. DePuy Synthes Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. DePuy Synthes Latest Developments
Table 92. Miracle Stretch Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 93. Miracle Stretch Piriformis Syndrome Product Offered
Table 94. Miracle Stretch Main Business
Table 95. Miracle Stretch Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Miracle Stretch Latest Developments
Table 97. Seirin Corporation Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 98. Seirin Corporation Piriformis Syndrome Product Offered
Table 99. Seirin Corporation Main Business
Table 100. Seirin Corporation Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Seirin Corporation Latest Developments
Table 102. Nidd Valley Medical Details, Company Type, Piriformis Syndrome Area Served and Its Competitors
Table 103. Nidd Valley Medical Piriformis Syndrome Product Offered
Table 104. Nidd Valley Medical Piriformis Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Nidd Valley Medical Main Business
Table 106. Nidd Valley Medical Latest Developments

LIST OF FIGURES

Figure 1. Piriformis Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Piriformis Syndrome Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Piriformis Syndrome Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Piriformis Syndrome Sales Market Share by Country/Region (2023)
Figure 8. Piriformis Syndrome Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Piriformis Syndrome Market Size Market Share by Type in 2023
Figure 10. Piriformis Syndrome in Hospitals
Figure 11. Global Piriformis Syndrome Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Piriformis Syndrome in Clinics
Figure 13. Global Piriformis Syndrome Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Piriformis Syndrome in Others
Figure 15. Global Piriformis Syndrome Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Piriformis Syndrome Market Size Market Share by Application in 2023
Figure 17. Global Piriformis Syndrome Revenue Market Share by Player in 2023
Figure 18. Global Piriformis Syndrome Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Piriformis Syndrome Market Size 2019-2024 ($ Millions)
Figure 20. APAC Piriformis Syndrome Market Size 2019-2024 ($ Millions)
Figure 21. Europe Piriformis Syndrome Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Piriformis Syndrome Market Size 2019-2024 ($ Millions)
Figure 23. Americas Piriformis Syndrome Value Market Share by Country in 2023
Figure 24. United States Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Piriformis Syndrome Market Size Market Share by Region in 2023
Figure 29. APAC Piriformis Syndrome Market Size Market Share by Type in 2023
Figure 30. APAC Piriformis Syndrome Market Size Market Share by Application in 2023
Figure 31. China Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Piriformis Syndrome Market Size Market Share by Country in 2023
Figure 38. Europe Piriformis Syndrome Market Size Market Share by Type (2019-2024)
Figure 39. Europe Piriformis Syndrome Market Size Market Share by Application (2019-2024)
Figure 40. Germany Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Piriformis Syndrome Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Piriformis Syndrome Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Piriformis Syndrome Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Piriformis Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 54. APAC Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 55. Europe Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 57. United States Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 58. Canada Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 61. China Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 62. Japan Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 63. Korea Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 65. India Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 66. Australia Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 67. Germany Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 68. France Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 69. UK Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 70. Italy Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 71. Russia Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 72. Spain Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 75. Israel Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Piriformis Syndrome Market Size 2025-2030 ($ Millions)
Figure 78. Global Piriformis Syndrome Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Piriformis Syndrome Market Size Market Share Forecast by Application (2025-2030)


More Publications